rinary neutrophil gelatinase-associated lipocalin(NGAL) excretion and Renal Functions in Mild Maternal Hydronephrosis

Not Applicable

Completed

• Conditions: Mild Maternal Hydronephrosis in Pregnancy; Renal and Urogenital - Kidney disease; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy

• Registration Number: ACTRN12614000455662
• Lead Sponsor: Emre Goksan Pabuccu

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-05-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 86

Inclusion Criteria

singleton pregnancies between 24-36 weeks of gestation without identifiable maternal and fetal disorders other than maternal hydronephrosis.

Exclusion Criteria

-Active urinary tract infection
-urolithiasis
-known genitourinary anomalies
-gestational or nongestational diabetes mellitus
-preeclampsia
-chronic hypertension
-chronic kidney or liver diseases
-chronic vascular or connective tissue diseases
The well-being of the fetus and the pregnancy was
established with a biophysical profile scoring. Pregnancies
with a jeopardized fetus, Bishop score over four, or active
labor were excluded.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rinary neutrophil gelatinase-associated lipocalin (NGAL) levels in terms of microgram/L per patient along with the review of patient medical records[on the day of ultrasonography (between 24-36th week of their pregnancy)]